Riskpilot← Back to searchSign inGet full accessMicroGen Aktiebolag
ABActiveOrg 5562821537Adolfsbergsvägen 36Engineering activities and related technical consultancy · NACE 7112Est. 19860 employees
Revenue 2024
SEK 0
EBITDA margin
—
+8% vs 2023
Equity ratio
94.0%
Financial strength
Net profit 2024
SEK -15K
-146% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -16K | +8% |
| Net profit | SEK -15K | -146% |
| Total assets | SEK 589K | -2% |
| Equity | SEK 554K | -3% |
| Employees | 0 | — |
Legal name
MicroGen Aktiebolag
Org number
5562821537
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
20 augusti 1986
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva forskning och utveckling av medicinska patent, utbildning och konsultverksamhet inom det medicinska området, handel med värdepapper, förvaltning av fast och lös egendom och därmed förenlig verksamhet.
Address
Adolfsbergsvägen 36
Phone
+46707382757
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | 0 | 0 |
| Staff expenses | — | −0 | −0 | −1 | −1 |
| EBITDA | −17 | −26 | −27 | −17 | −16 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −17 | −26 | −27 | −17 | −16 |
| Net financials | — | 77 | −0 | 49 | 1 |
| Profit before tax | −17 | 51 | −27 | 32 | −15 |
| Tax | −0 | −7 | — | — | — |
| Net profit | −17 | 44 | −27 | 32 | −15 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 529 | 596 | 576 | 599 | 589 |
| Equity | 519 | 563 | 536 | 568 | 554 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 10 | 33 | 40 | 31 | 35 |
| Total debt | 10 | 33 | 40 | 31 | 35 |
EBITDA margin
-1573300.0%
This company
15.8%
Market median
-9957695% vs market
20202024
Equity ratio
94.0%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
-2.7%
This company
18.4%
Market median
-115% vs market
20202024
Net profit margin
-1468600.0%
This company
8.1%
Market median
-18130964% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MicroGen Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Arne Löfdahl | Board of Directors | 0 companies |
| Margareta Kristina Löfdahl | Deputy Board Member | 0 companies |